Chronic cancer patients face ongoing health challenges, especially with compromised immune systems, necessitating regular antibody infusions for protection. Exposure to illness can lead to ...
CHICAGO – Patients with colorectal cancer who had acneiform rash and applied LUT014 gel, an investigational topical BRAF inhibitor, were more likely to experience improvement of their rash compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback